Fortis Healthcare 30th AGM on Aug 11, 2026
Fortis Healthcare Limited will hold its 30th Annual General Meeting on August 11, 2026, through video conferencing. The agenda includes adopting financial statements for FY 2025-26 and approving a final dividend of ₹1 per share. Special resolutions cover the re-appointment of Dr. Ashutosh Raghuvanshi as MD & CEO, remuneration for Independent Directors, and cost auditor ratification. The company reported a consolidated net profit of ₹1,06,418.79 lacs for the year.
*this image is generated using AI for illustrative purposes only.
Fortis Healthcare Limited will convene its 30th Annual General Meeting (AGM) on Tuesday, August 11, 2026, at 12:00 hours IST through Video Conferencing and Other Audio Visual Means (VC/OAVM). The meeting will transact both ordinary and special business as outlined in the AGM notice, with members participating remotely counted for quorum purposes under Section 103 of the Companies Act, 2013. The AGM notice and Annual Report for FY 2025-26 were dispatched on July 17, 2026 to shareholders with registered email addresses.
Key AGM Schedule
The following table summarises the critical dates and timelines for the 30th AGM:
| Event: | Date | Time (IST) |
|---|---|---|
| Record Date for Dividend | Friday, July 24, 2026 | Not Applicable |
| Cut-off Date for E-voting | Tuesday, August 4, 2026 | Not Applicable |
| E-voting Commencement | Thursday, August 6, 2026 | 9:00 A.M. |
| E-voting End | Monday, August 10, 2026 | 5:00 P.M. |
| 30th AGM | Tuesday, August 11, 2026 | 12:00 P.M. |
| Final Dividend Payment (on or before) | Wednesday, September 9, 2026 | — |
| Results Declaration (on or before) | Thursday, August 13, 2026 | 6:00 P.M. |
| Speaker Registration Window | July 21, 2026 – August 6, 2026 | — |
Ordinary Business
Shareholders will be asked to receive and adopt the audited standalone and consolidated financial statements for the year ended March 31, 2026, along with the Board and Auditors' reports. The Board has recommended a final dividend of ₹1 per equity share for FY 2025-26, subject to shareholder approval. The record date for dividend payment is Friday, July 24, 2026, and the Register of Members will remain closed from July 25, 2026 to August 11, 2026 (both days inclusive).
The meeting will also consider the re-appointment of Mr. Ashok Pandit (DIN: 09279899) and Dr. Prem Kumar Nair (DIN: 10348774), Non-Executive Non-Independent Directors retiring by rotation, both of whom are eligible and have offered themselves for re-appointment.
Special Business
The AGM agenda includes four special resolutions. The following table outlines the key proposals:
| Resolution: | Details |
|---|---|
| Item 5 – Cost Auditor Remuneration | Ratification of remuneration of up to ₹2,95,000 to M/s. Jitender, Navneet & Co. (Firm Reg. No. 000119) for FY ended March 31, 2026 |
| Item 6 – Independent Director Commission | Approval to pay commission to Independent Directors for three years effective April 1, 2027 to March 31, 2030; up to ₹77,17,500 per annum per Independent Director and up to ₹1,95,00,000 per annum to the Chairman (if Independent Director) |
| Item 7 – Leo Puri Remuneration | Approval for payment of commission of ₹1,95,00,000 to Mr. Leo Puri (DIN: 01764813), Non-Executive Independent Chairperson, for FY 2025-26, which exceeds 50% of total annual remuneration payable to all Non-Executive Directors |
| Item 8 – MD & CEO Re-appointment | Re-appointment of Dr. Ashutosh Raghuvanshi (DIN: 02775637) as Managing Director & CEO for two years effective March 19, 2027, with salary and perquisites of up to ₹11,23,46,000 per annum |
Financial Performance Highlights (FY 2025-26)
The following financial results, as disclosed in the AGM notice, underpin the remuneration proposals:
| Particulars: | Standalone (₹ in Lacs) | Consolidated (₹ in Lacs) |
|---|---|---|
| Turnover | 1,79,249.50 | 9,12,784.18 |
| Other Income | 16,518.17 | 5,066.16 |
| Net Profit After Tax | 23,034.29 | 1,06,418.79 |
E-Voting and Participation
The remote e-voting facility is provided by National Securities Depository Limited (NSDL). Members holding shares as of the cut-off date of August 4, 2026 are eligible to vote electronically. Shareholders who have cast their votes remotely may attend the AGM via VC/OAVM but will not be permitted to vote again during the meeting. Mr. Mukesh Agarwal (C.P. No. 3851) of M/s Mukesh Agarwal & Co., Practicing Company Secretaries, has been appointed as the Scrutinizer. The AGM is being held in compliance with the Companies Act, 2013, SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and applicable MCA and SEBI circulars.
Historical Stock Returns for Fortis Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.50% | +0.21% | -1.06% | +12.73% | +20.35% | +307.47% |
What strategic initiatives is Fortis Healthcare pursuing to sustain the consolidated net profit growth of ₹1,06,418.79 lacs?
How will the re-appointment of Dr. Ashutosh Raghuvanshi as MD & CEO influence the company's expansion plans over the next two years?
What impact will the approved commission for Independent Directors have on shareholder sentiment and corporate governance standards?
16
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
